Table 3: Post-operative treatment for patients treated with SIOP 2001 protocol that had immediate operation.
Patients | Treatment regimen |
Stage I, intermediate risk (exclude focal anaplasia) | 1: 10 weeks of Vincristine |
Stage I focal anaplasia Stage II, Low and intermediate risks |
2: 26 weeks with Vincristine and Actinomycin D |
Stage III, IR (include focal anaplasia) | 3: 28 weeks with Vincristine, Actinomycin D, Doxorubicin and Radiotherapy |
Stage I-IV High risk | As for patients with preoperative chemotherapy |